| Document Date: 2012-06-27 15:01:56
Open Document File Size: 1,14 MBShare Result on Facebook
City Denver / Cambridge / / Company Momenta Pharmaceuticals Inc. / Takashi K. Kishimoto Momenta Pharmaceuticals Inc. / / IndustryTerm bioluminescent imaging / vivo real-time bioluminescent imaging / / MedicalCondition inhibited tumor / cancer metastasis / tumor / experimental cancer / cancer / tumors / tumor metastasis / Tumor Cells MONC402 / Selectin interactions mediating tumor / metastasis / Breast Cancer Tumor Metastasis / 4T1 murine breast cancer / lung tumor / several tumor / P-Selectin-mediated tumor / 4T1 breast carcinoma / / Organization American Association for Cancer Research / / Person Jay Duffner / Nancy Dussault / Lin Chu / Birgit C. Schultes / Van Noorden / Alison Long / Erick Moy / / Product cisplatin / Taxol / paclitaxel / Taxotere / / ProvinceOrState Massachusetts / Colorado / / PublishedMedium Cancer Research / / Technology pharmacokinetics / /
SocialTag |
Abstract # 5005 M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane Z